CompletedPHASE1, PHASE2NCT01584388
Rituximab in IgG4-RD: A Phase 1-2 Trial
Studying Autoimmune pancreatitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- John H Stone, MD, MPHMassachusetts General Hospital (Rheumatology Unit)
- Intervention
- Rituximab(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2015
Collaborators
Genentech, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01584388 on ClinicalTrials.govOther trials for Autoimmune pancreatitis
Additional recruiting or active studies for the same condition.